Updated:
Jiuying Investment Management
Jiuying Investment Management is a private equity based in Guangzhou; the Altss profile covers its classification, headquarters, registration, AUM band, and...
Jiuying Investment Management
Jiuying Investment Management is a private equity firm based in Guangzhou, China. It focuses on venture capital investments.
General information
Firm type
Private Equity
Location
Region
Asia
Country
China
City
Guangzhou
Corporate office
Guangzhou, China
Sector focus
Frequently asked questions
What investment stages does Jiuying Investment Management target?
Jiuying operates across a broad range of stages, from seed and start-up venture rounds through growth equity and PIPE transactions. This full-spectrum approach allows the firm to support portfolio companies from early formation through pre-IPO financing and, where relevant, public-market restructuring. The PIPE capability is a differentiator from pure early-stage venture firms in the Guangzhou region.
How does Jiuying's Guangzhou location affect its deal sourcing?
Guangzhou anchors Jiuying in the Pearl River Delta, a manufacturing and export hub with a dense network of hardware, industrial automation, and supply-chain software companies. This geography offers sourcing advantages in advanced manufacturing and industrial technology that are less readily accessible to Beijing or Shanghai-headquartered funds. The firm can exploit proximity-based relationships where rival managers must rely on episodic travel-based origination.
Does Jiuying manage RMB or USD funds?
Jiuying operates within the domestic RMB fund ecosystem, a structure that reflects both its LP base and the regulatory environment governing Chinese private equity since the 2021 clampdown on offshore variable-interest-entity listings. RMB-denominated funds typically pursue domestic A-share listings or strategic sales to Chinese acquirers as primary exit paths, rather than US or Hong Kong IPOs.
Which sectors does Jiuying explicitly avoid?
Jiuying's disclosed strategy centers on enterprise software, AI and machine learning, digital health, and industrial technology. There is no public evidence of material allocation to consumer internet, real estate, financial services, or biotech drug discovery — sectors that carry distinct regulatory or cyclical risks in the current Chinese policy landscape. This pattern suggests a deliberate tilt toward areas aligned with state industrial policy and away from sectors facing populist regulatory headwinds.
What is Jiuying's known posture on co-investments alongside other GPs?
The firm's co-investment practices have not been publicly detailed. However, the PIPE mandate implies a willingness to transact in public-market structures where multiple investors participate in a single placement, which functionally resembles co-investing. Whether Jiuying actively syndicates early-stage rounds with other venture firms remains undisclosed.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: